A more comprehensive investigation of these questions will need to be performed in an appropriate follow up cohort such as the recently completed Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) trial63. The gene discussed is IL2; the disease is diabetes mellitus.